
Lokon Pharma | Home
Lokon Pharma is a Swedish biotech company in the forefront of developing tumor microenvironment (TME) gene engineering vectors for cancer. Innovative gene engineering, …
About us - Lokon Pharma
Lokon Pharma is a Swedish biotech company in the forefront of developing tumor microenvironment (TME) gene engineering vectors for cancer.
Our Solution - Lokon Pharma
Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main focus.
Pipeline - Lokon Pharma
Lokon Pharma focuses on the development of LOAd therapy for different types of cancer and in combination with other cancer therapeutics including chemotherapy and checkpoint blockade …
Lokon Pharma | Home
Lokon Pharma is a Swedish biotech company in the forefront of developing immunostimulatory gene therapy for cancer based on oncolytic viruses. Innovative gene engineering, solid …
Lokon Pharma | För patienter
Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main focus.
Lokon Pharma | News
Lokon Pharma Announces Collaboration to Combine LOAd703 Oncolytic Virotherapy with Checkpoint Blockade in Pancreatic Cancer and Melanoma
For patients - Lokon Pharma
Lokon Pharma AB is committed bringing innovative medicinal products that are safe and proven effective to patients. At the present time, we are focused on conducting clinical trials needed to …
Career - Lokon Pharma
Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main focus.
Lokon Pharma | News
Lokon Pharma Announces Collaboration to Combine LOAd703 Oncolytic Virotherapy with Checkpoint Blockade in Pancreatic Cancer and Melanoma